Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00386945 · ClinicalTrials.gov registry record · NA

Tobacco Cessation Via Doctors of Chiropractic

A NA study of Tobacco Use Cessation, sponsored by Oregon Research Institute.

Completed
Registry status
NA
Development phase
201
Enrollment target
1
Study location

NCT00386945: Completed NA study of Tobacco Use Cessation, sponsored by Oregon Research Institute.

NCT00386945 is a NA study of Tobacco Use Cessation that has completed, run by Oregon Research Institute. The registered enrollment target is 201 participants, below the 879-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00386945, a NA study of Tobacco Use Cessation, has completed, sponsored by Oregon Research Institute.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to develop an office-based tobacco intervention for chiropractic patients.

Conditions Studied

Interventions

  • BEHAVIORAL Brief counseling (Ask, Advise, Arrange)

Study Locations (1)

Oregon

  • Oregon Research Institute - Eugene

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2006-05
Est. Completion 2008-05
Phase NA
Oregon Research Institute

62 total trials

What the finished NCT00386945 record still lists

NCT00386945 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 879-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 1 intervention - of which Brief counseling (Ask, Advise, Arrange) is the first listed.

NCT00386945 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT00386945 about?

NCT00386945 is a clinical study titled "Tobacco Cessation Via Doctors of Chiropractic". The purpose of the study is to develop an office-based tobacco intervention for chiropractic patients.

What is the current status of trial NCT00386945?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2006-05. Estimated completion is 2008-05.

What conditions does trial NCT00386945 study?

This clinical trial studies the following conditions: Tobacco Use Cessation.

What interventions are being tested in trial NCT00386945?

The interventions under investigation include: Brief counseling (Ask, Advise, Arrange) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00386945?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00386945 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00386945's enrollment target sits among peer trials

201 20th of 36 higher than 17 of 36 other Tobacco Use Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04422652 · 201 participants · Phase 2

    Combination of Novel Therapies for CKD Comorbid Depression

  • NCT05327114 · 201 participants · Phase 2

    Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • NCT06099769 · 201 participants · Phase 2

    A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  • NCT06274528 · 201 participants · Phase 2

    DORA and LP in Alzheimer's Disease Biomarkers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00386945, the US trial registry maintained by the National Library of Medicine. NCT00386945 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.